Rupert Derler is a Senior Scientist at CPTx, focusing on the development and characterization of DNA-based nanotherapeutics while serving as a strategic project lead. Previously, Rupert held the position of Scientist in Technology Development at Ascend Advanced Therapies, where they specialized in AAV vector production technologies for gene therapy. Their experience spans roles as a QC Scientific Officer at Thermo Fisher Scientific, an Analytical Scientist at Oxford BioMedica, and a Research Assistant at Antagonis Biopharmaceuticals. Rupert also contributed to academia as a lecturer at Karl-Franzens-Universität Graz, teaching pharmaceutical analytics and related subjects.
This person is not in any teams
This person is not in any offices